Thank you for visiting us. We are currently updating our shopping cart and regret to advise that it will be unavailable until September 1, 2014. We apologise for any inconvenience and look forward to serving you again.

Wiley
Wiley.com
Print this page Share

Emerging Technology Platforms for Stem Cells

ISBN: 978-0-470-14693-4
521 pages
April 2009
Emerging Technology Platforms for Stem Cells (0470146931) cover image
This book focuses on practical applications for using adult and embryonic stem cells in the pharmaceutical development process. It emphasizes new technologies to help overcome the bottlenecks in developing stem cells as therapeutic agents. A key reference for professionals working in stem cell science, it presents the general principles and methodologies in stem cell research and covers topics such as derivitization and characterization of stem cells, stem cell culture and maintenance, stem cell engineering, applications of high-throughput screening, and stem cell genetic modification with their use for drug delivery.
See More
Foreword Current state of stem cell field: Overview (Mahendra S. Rao).

Chapter 1: Derivation methods for human embryonic stem cells: Past, present & future Necati Findikli.

Mohan Vemuri.

Chapter 2: Isolation of human ESCs from various stages of the human embryo (Yuri Verlinsky, N. Strelchenko, V. Kukharenko, A. Shkumatov, S. Rechitsky, O. Verlinsky, and A. Kuliev).

Chapter 3: Derivation of stem cells from epiblasts (Michal Amit).

Chapter 4: Derivation of Embryonic Stem Cells from Parthenogenetic Eggs (Jose Cibelli).

Chapter 5: Reprogramming Developmental Potential (Costas A. Lyssiotis Cradley D. Charette, and Luke L. Lairson).

Chapter 6: Adult stem cells and their role in endogenous tissue repair (N. Sachewsky and Cindi Morshead).

Chapter 7: Greater differentiation potential of adult stem cells (Carlos Clavel and Catherine Verfaillie).

Chapter 8: Cancer stem cells (Scott Dylla, In-Kyung Park and Austin L. Gurney).

Chapter 9: Large scale production of adult stem cells for clinical use (Kristin Goltry, Brian Hampson, Naia Venturi and Ronnda Bartel).

Chapter 10: Genetic and epigenetic features of stem cells (Jonathan Auerbach and Richard Josephson).

Chapter 11: Directed differentiation of embryonic stem cells (Marjorie Pick).

Chapter 12: Identification of signaling pathways involved during differentiation Takumi Miura.

Chapter 13 Media and extracellular matrix requirements for large scale ESC growth (Allan J. Robins and Tom Schultz).

Chapter 14: Automated method for culturing ES cells (S. Terstegge and Oliver Brustle).

Chapter 15: Quantitative 2D Imaging of Human Embryonic Stem Cells (Steven K.W. Oh, Allen K. Chen, Andre B.H. Choo and Ivan Reading).

Chapter 16: Nanobiotechonology for stem cell culture and Maintenance (Minseok S. Kim, Wonhye Lee and Je-Kyun Park).

Chapter 17: Engineering Microenvironments to Control Stem Cell Functions (Anielle An-Chi Tsou and Song Li).

Chapter 18: Improved lentiviral gene delivery tools for stem cells (Sanjay Vasu, Jian-Ping Yang and Wieslaw Kudlicki).

Chapter 19: Sleeping Beauty-mediated Transposition in Stem Cells (Andrew Wilbur, Jakub Tolar, Bruce R Blazar, Catherine M Verfaillie, Uma Lakshmipathy, Dan S Kaufman and Scott McIvor).

Chapter 20: PhiC31 Integrase for Modification of Stem Cells (W. Edward Jung and Michelle Calos).

Chapter 21: Cell Engineering using Integrase and Recombinase systems (Takefumi Sone, Fumiko Nishi, Kazuhide Yahata, Yukari Sasaki, Hiroe Kishine, Taichi Andoh, Ken Inoue, Bhaskar Thyagarajan, Jonathan D. Chesnut and Fumio Imamoto).

Chapter 22: hESC derived cardiomyocytes for cell therapy and drug discovery (William Sun and Robert Zweigerdt).

Chapter 23: hESC in Drug discovery (Catharina Ellerstrom, Petter Bjorquist, Peter Sartipy, Johan Hyllner and Raimund Strehl).

Chapter 24: Characterization and Culturing of Adipose-Derived Precursor Cells (Dietmar Hutmacher, Joanna Olkowska-Truchanowicz, David Leong, Johannes Reichert and Thiam Chye Lim).

Chapter 25: Bringing Mesenchymal stem cells to clinic (Robert Deans).

See More

Uma Lakshmipathy is a Principal Scientist at Life Technologies. She has a PhD in life sciences, with academic and industry experience in molecular biology and stem cells. Dr. Lakshmipathy holds two patents and has authored over thirty publications.

Jonathan D. Chesnut is an R & D Director at Life Technologies, where he heads the stem cell engineering group. He holds five patents and has authored over twenty publications.

Bhaskar Thyagarajan is a Program Manager at Life Technologies. He has a PhD in pharmacology, with expertise in the areas of molecular biology, DNA recombination, gene and cell therapy, and protein purification. He holds one patent and has authored over twenty publications.

See More
Buy Both and Save 25%!
+

Emerging Technology Platforms for Stem Cells (US $150.00)

-and- Primary and Stem Cells: Gene Transfer Technologies and Applications (US $119.00)

Total List Price: US $269.00
Discounted Price: US $201.75 (Save: US $67.25)

Buy Both
Cannot be combined with any other offers. Learn more.

Related Titles

Back to Top